Prevalence of Cryptosporidium Infection in Immunocompromised Patients, In South-West of Iran, 2009-10
,
Abstract
Background: Cryptosporidium is a protozoan parasite with worldwide distribution. The aim of this study was to estimate the prevalence of Cryptosporidium infection by antigen detection in faeces among immunocompromised patients referred to educational hospitals of Ahvaz City, South-West of Iran, 2009-2010.
Methods: Fecal samples from 176 immunocompromised patients were collected and Cryptosporidium coproantigen test was performed using ELISA method (DRG kit, Germany). A questionnaire was completed for each case and the results were analyzed using descriptive and Chi-Square tests, by SPSS statistical software (15th version).
Results: Our study indicated 5.1% Cryptosporidium infection prevalence in the immunocompromised participated population. Furthermore, 4.2 %, 4%, 4.5 % and 9.1% infection rates were identified in children suffered from hematopoietic malignancy, adult cancer patients, renal transplant recipients, and HIV+ cases, respectively. There was not significant correlation between the infection and age and gender (P>0.05). Infection was most frequent among HIV+ patients.
Conclusion: The present study confirmed the high prevalence of Cryptosporidium antigen in fecal samples of immunocompromised patients in the region. As no chemotherapeutic agents have yet proven, especially in immunosuppressed patients, therefore our results highlight the importance of preventive intervention in these groups.
Gerald DS, Larry SR. Foundations ofparasitology. 7th ed. Mc Graw Hill Companies; 2006:141-42.
Havelar A, Boonyakarnkul T, Cunliffe D, et al. Guidelines for drinking water qulity, water born pathogens. Geneva:WHO; 2003.
Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systemic review and meta analysis. Br J Clin Phamacol. 2007;63(4):387-93.
Paul RH, Gordon N. Epidemiology and clinical features of Cryptosporidium infection in immunocompromise patients. Clin Mic Reviews. 2002;15(1):145-54.
Nahrevanian H, Assmar M. Cryptosporidiosis in immunocompromised patients in the Islamic Republic of Iran. J Microbiol Immunol Infect. 2008;41:74-77.
Hazrati Tappeh Kh, Gharavi MJ, Mkhdoumi K, Rahbar M, Taghizadeh H. Prevalence of Cryptosporidium sp. infection in renal transplant and heamodialysis Iranian patients. Iranian J Publ Health. 2006; 35(3):54-57.
Berenji F, Zabolinejad N, Kianifar HR, Badeii Z, Banihashem A, Hiradfar S. Cryptosporidium infection in pediatric patientsm with lymphohematopoietic malignancies. Iran J Ped. 2007; 17(3):247-51.
Taherkhani H, Fallah M, Jadidian K, Vaziri S. A study on the prevalence of, Cryptosporidium in HIV positive patients. J Res Health Sci. 2007;7(2):20-24.
Ballal M, Prabhu T, Chadran A, Shivananda P. Cryptosporidium and Isospora belli diarrhea in immunocompromised hosts.. Indiana J Cancer. 1999;Mar;36(1):38-42.
Ramakrishnun K, S Rajaiah Shenbarathai, Uma A. Prevalence of intestinal parasitic infestation in HIV/AIDS patients with diarrhea in Madurai City, South India. Jpn J Infect Di. 2007; 60(4):209-10.
Tany M. Prevalence of Cryptosporidium spp in patients with neoplasia and diarrhea. Sand J Infect Dis. 1995; 27(1):69-70.
Arikan S, Ergn,Aky Y, Glp A. Cryptosporidiosisin immunocompromised patients in a Turkish university hospitals. Acta Microbial Immuno Hung. 1999; 46(1):33-40.
Mirzaei M. Prevalence of Cryptosporidium sp infection in diarrheic humans in Iran. Kor J Parasitol. 2007; 45(2):133-37.
Meamar AR, Rezaian M, Mohraz M, Zahabiun F, Hadighi R, Kia EB. A comparative analysis of intestinal parasitic infection between HIV+/AIDS patients and non infected individuals. Indian J Parasitol. 2007; 2(1):1-6.
Nahrvanian H, Assmar M. A case report of cryptosporidiosis and isosporidiasis in AIDS patients in Iran. J Trop Med Parasitol. 2006; 29:33-6.
Nateghi Rostami M, Keshavarz H, EskandariE, Kia EB, Rezaeian M. Intestinal parasitic infections in renal transplant recipients. Iranian J Parasitol. 2007; 2(3):16-23.
Valar C, Keitel E, Dal Pra Rl, Gnatta D, Santos AF. Parasitic infection in renal transplant recipients. Transplant Proc. 2007; 39:460-2.
Ok UZ, Cirit M, Uner A, Akcicek F, Basic A, Ozcel MA. Cryptosporidiosis and blastocystosis in renal transplant recipients. Nephron. 1997; 75:171-74.
Minz M, Udgiri NK, Heer MK, Kashyap R. Cryptosporidiosis in live related renal transplant recipients: A single center experience. Transplant. 2004; 77:1916-17.
Chappell LH, Wastling JM. Cyclosporin A: antiparasite drug modulator of the host parasite relationship and immunosuppressant. Parasitol.1992; 105:25-40.
Hassan SI, Sabry H, Amer NM, Shalaby M A, Mohamed NA, Gaballah H. Incidence of cryptosporidiosis in immunodeficient cancer patients in Egypt. J Egypt Soc Parasitol. 2002; 32(1):33-46.
Rivera WL, Yason J A, Riveran PT. Serologicaldetection of cryptosporidiosis among Filipino cancer patients. Parasitol Res. 2005; 98(1):75-76.
Baqai R, Anwar S, Kazmi SU. Detection of Cryptosporidium in immunosuppressed patients. J Ayub Col Abbottabad. 2005; 17(3):38-40.
Barbieri M, Server MA, Pirez MI, Battiston J, Nietto A. Use of specific antibody and circulating antigen serum levels in the hydatid immunodiagnosis of asymptomatic population. Inter J Parasitol.1994; 24(7):937-42.
Jayalakshmi J, Appalaraju B, Mahadevan K. Evaluation of an enzyme-linked immunoassay for detection of Cryptosporidium antigen in fecal specimens of HIV/AIDS patients. Indian J Pat Microb; 2008;51(1):137-38.
Ungar BL. Enzyme-linked immunoassay for detection of Cryptosporidium antigens in fecal specimens. J Clin Microbiol. 1990; 28:2491-5.
| Files | ||
| Issue | Vol 5 No 4 (2010) | |
| Section | Articles | |
| Keywords | ||
| Cryptosporidium Coproantigen Immunocompromised patients ELISA human Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
